Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a progressive and fatal fibrosing lung disease of unknown cause. The advent of anti-fibrotic medications known to slow disease progression has revolutionised IPF management in recent years. However, little is known about the natural history of IPF p...

Descripción completa

Detalles Bibliográficos
Autores principales: Jo, Helen E., Glaspole, Ian, Moodley, Yuben, Chapman, Sally, Ellis, Samantha, Goh, Nicole, Hopkins, Peter, Keir, Greg, Mahar, Annabelle, Cooper, Wendy, Reynolds, Paul, Haydn Walters, E., Zappala, Christopher, Grainge, Christopher, Allan, Heather, Macansh, Sacha, Corte, Tamera J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785886/
https://www.ncbi.nlm.nih.gov/pubmed/29370786
http://dx.doi.org/10.1186/s12890-018-0575-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5785886/
https://www.ncbi.nlm.nih.gov/pubmed/29370786
http://dx.doi.org/10.1186/s12890-018-0575-y

Ejemplares similares